Overview
Reveal HealthTech provides technology solutions and consulting for digital health, helping healthcare innovators develop, optimize, and scale products so they reach the market faster. The company offers tailored tech services and advisory, working with a client’s team from ideation to launch to shorten time-to-market while ensuring usability, quality, and safety. It differentiates itself through clinical insight led by Chief Medical Innovation Officer Dr. Salim Afshar, aligning offerings with real clinical needs and focusing on risk reduction for startups, medical practices, and health investors. The goal is to help healthcare teams bring safe, usable, and scalable digital health products to market efficiently, lowering development risk and speeding adoption.
Work here?Claim your company
Simplify's take
What believers are saying
- September 2025 Series A raised $7.2 million from Leo Capital and Sanos Capital.
- The 2026 website shows active productization, not just bespoke services, improving margin potential.
- CancerX partnership and Cipher Collective membership expand U.S. healthcare credibility and deal flow.
What critics are saying
- Revenue depends on winning services contracts; no recurring SaaS scale is visible in 2026.
- Competitors like EPAM, Cambay, and boutique AI studios can copy this services-heavy model quickly.
- If BioCanvas adoption stalls by 2027, Reveal becomes a small consulting shop, not a platform company.
What makes Reveal Health Tech unique
- Reveal HealthTech pairs clinical expertise, engineering, and strategy for healthcare builds.
- BioCanvas and PrismAI target clinical-trial recruitment and workflow automation, launched on the 2026 website.
- AWS Advanced Tier Partner status supports regulated healthcare deployments and cloud migrations.
Help us improve and share your feedback! Did you find this helpful?